Related Experiment Video
Updated: Aug 10, 2026

Monitoring the Assembly of a Secreted Bacterial Virulence Factor Using Site-specific Crosslinking
Published on: December 17, 2013
Basic streptococcal superantigens (SPEX/SMEZ or SPEC) are responsible for the mitogenic activity of the so-called
D Gerlach1, K H Schmidt, B Fleischer
1Friedrich-Schiller-Universität Jena, Institute for Medical Microbiology, Semmelweisstr, 4, D-07743 Jena, Germany. i9gedi@rz.uni-jena.de
Abstract:
The mitogenic factor (MF) of group A streptococci has been reported to be a superantigen stimulating human T cells carrying Vbeta2, 4 and 8 and has been designated streptococcal pyrogenic exotoxin F (SPEF). MF was also shown to possess DNase activity. Here we have purified MF from culture supernatants of different Streptococcus pyogenes strains. Surprisingly, the MF preparations from different strains showed different Vbeta specificities depending on the expression of SPEC or SMEZ3 by the producing strain. Their mitogenic activity decreased upon further purification. In addition, the mitogenic activity could be only neutralized by antibodies against the basic streptococcal superantigens SPEC or SPEX (SMEZ3) but not by antibodies against MF itself although the latter were able to neutralize completely the DNase activity of MF. We found that streptodornase type B (SDB) was expressed in two molecular forms (SDBI and SDBII), differing only by one additional N-terminal arginine at SDBI. MF was found identical to the enzyme SDBII but is devoid of superantigenic properties and should no longer be called a superantigen or a pyrogenic exotoxin.
Insights
Group A Streptococcus mitogenic factor (MF) is not a superantigen but a DNase enzyme (streptodornase type B). MF
Area of Science:
- Microbiology
- Immunology
- Enzymology
Background:
- Group A Streptococcus mitogenic factor (MF) was previously identified as streptococcal pyrogenic exotoxin F (SPEF), a superantigen.
- MF possesses both mitogenic and DNase activities.
- Superantigens are known to stimulate T cells via specific Vbeta chains.
Purpose of the Study:
- To purify and characterize the mitogenic factor (MF) from Streptococcus pyogenes.
- To determine the precise nature of MF's superantigenic and DNase activities.
- To clarify the classification of MF, specifically its relationship to superantigens and DNases.
Main Methods:
- Purification of MF from culture supernatants of various Streptococcus pyogenes strains.
- Assessment of Vbeta specificity of MF preparations.
- Neutralization assays using antibodies against known streptococcal superantigens (SPEC, SPEX/SMEZ3) and MF.
- Analysis of DNase activity of MF.
- Molecular characterization of streptodornase type B (SDB) and comparison with MF.
Main Results:
- MF preparations from different strains exhibited varying Vbeta specificities, linked to SPEC or SMEZ3 expression.
- Mitogenic activity decreased with purification and was neutralized by anti-SPEC/SPEX antibodies, not anti-MF antibodies.
- DNase activity of MF was completely neutralized by anti-MF antibodies.
- MF was identified as streptodornase type B isoform II (SDBII), lacking superantigenic properties.
- SDBII differs from SDBI by an additional N-terminal arginine.
Conclusions:
- Mitogenic factor (MF) from Group A Streptococcus is identical to streptodornase type B isoform II (SDBII).
- MF lacks superantigenic properties and should be reclassified, no longer termed a superantigen or pyrogenic exotoxin.
- The study clarifies the dual activity of MF, attributing mitogenicity to superantigen contamination or interaction and the primary function to DNase activity.
More Related Videos
Related Concept Videos
Staphylococcal Skin Infections
Clinical Significance of Antibiotic Resistance

